Enteric coated, sustained release, immediate release and MUPS pellets for capsule and multiparticulate tablet formulations.
Enteric Coated Pellets • Sustained Release Pellets • MUPS Pellets • DC Granules • APIs • Intermediates
Pharmaceutical pellets are small, free-flowing spherical units that carry a drug in a controlled way. Because each dose is split across many pellets, release is more reproducible than with a single-unit tablet, and different pellet populations can be combined in one capsule to deliver two actives or two release phases.
Rraynex manufactures pellets in the release formats formulators ask for most: enteric-coated (EC) and delayed-release pellets for acid-sensitive actives such as proton pump inhibitors, sustained-release (SR) and extended-release pellets for once-daily dosing, immediate-release (IR) pellets, multiple-unit pellet system (MUPS) pellets for compression into tablets, and fixed-dose combination pellets.
Every product below has its own page with available strengths, grade and supply information, and an enquiry form that keeps the product reference attached to your request.
Analgesic and anti-inflammatory pellets engineered for cardiovascular support regimens. Uniform pellet size and controlled moisture deliver reliable dissolution in low-dose aspirin therapies.
WHO-GMP compliant anti-platelet pellets supporting secondary prevention of atherothrombotic events. Built for consistent layering to maintain bioavailability in fixed-dose combinations.
Dual anti-platelet pellets that balance particle size between both actives, streamlining fixed-dose regimens for post-PCI maintenance and high-risk cardiovascular patients.
Enteric-coated pellets formulated for serotonin-norepinephrine reuptake inhibitor therapies addressing depression, neuropathic pain, and generalized anxiety disorders.
Dual delayed-release pellets targeting extended acid suppression, ideal for once-daily GERD control with staged gastric release.
Multiparticulate pellets for flexible delayed-release formulation development in proton pump inhibitor programs.
Enteric-coated esomeprazole pellets with tight moisture control to maintain proton pump inhibition for GERD and erosive esophagitis regimens.
Magnesium-trihydrate based pellets built for high acid resistance and rapid dissolution convergence, supporting chronic GERD therapy.
Bilayered pellets combining acid suppression with prokinetic support, engineered to minimise segregation in capsule fills.
Beyond catalogue products, Rraynex offers pellet development from pilot to commercial scale, pellet coating, contract manufacturing and technology transfer. The team can share DMF access, stability data and custom formulation options for your project.